ClinicalTrials.gg
Not yet recruitingNCT07939256Updated Nov 16, 2026

Comparing Effect of Shock Wave Alone Versus Shock Wave With Traditional Physical Therapy for Tennis Players With Chronic Supraspinatus Tendinitis

An interventional study of Extracorporeal Shock Wave Therapy (ESWT) and Shock Wave Therapy with Traditional Physical Therapy in Chronic Supraspinatus Tendinitis in Tennis Players, sponsored by Kafrelsheikh University. Not yet recruiting. Open to participants aged 16 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Kafrelsheikh University · Not applicable, Interventional, and Treatment

Updated Nov 16, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
16 Years to 65 Years
Sex
All
01

Study summary

Study Goal: To compare the effect of shock wave therapy alone versus shock wave therapy combined with traditional physical therapy for tennis players suffering from chronic supraspinatus tendinitis.

Study Design: A pre-post randomized controlled experimental trial where participants are randomly assigned into two equal groups.

Participants: 70 tennis players of both genders (aged 16 to 65 years) with chronic supraspinatus tendinitis, divided into 35 participants per group.

Intervention \& Duration: The treatment period consists of 12 sessions spanning one and a half months.

Evaluation Metrics: Shoulder range of motion (measured via electronic goniometer), shoulder pain (measured via numeric anlage scale), and shoulder function (assessed via shoulder joint functional index).

02

Conditions studied

  • Chronic Supraspinatus Tendinitis in Tennis Players

Browse trials for

Keywords

  • Shock wave therapy (ESWT)
  • traditional physical therapy
  • tennis players
  • chronic supraspinatus tendinitis
03

In context

Tendinopathy

397 studies on the registry are indexed under Tendinopathy; 77 are open to participants now.

This study's planned enrollment of 70 is above the median of 48 across 332 interventional studies indexed under Tendinopathy.

Browse Tendinopathy studies →

Lead sponsor

Kafrelsheikh University is the lead sponsor of 300 studies on the registry; 119 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Tennis players
  • Diagnosed with chronic supraspinatus tendinitis
  • Aged 16 to 65 years
  • Of both genders
  • Willing to sign a consent form according to the Helsinki Protocol

Exclusion criteria

Exclusion Criteria:

  • A history of previous shoulder surgery or fracture on the affected side.
  • Full-thickness rotator cuff tears confirmed by clinical evaluation or imaging.
  • Receipt of a local injection in the affected shoulder within the past three months.
  • Presence of acute shoulder trauma, dislocation, or severe joint instability.
  • Concomitant shoulder pathologies such as adhesive capsulitis (frozen shoulder) or referred pain from cervical radiculopathy.
  • Bleeding disorders or ongoing anticoagulant therapy that may contraindicate shock wave treatment.
  • Presence of a cardiac pacemaker or metallic implants in the shoulder region.
  • Pregnancy or lactation.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    Shock Wave Therapy Alone

    Procedure: Extracorporeal Shock Wave Therapy (ESWT)

  • Active comparator
    Shock Wave Therapy with Traditional Physical Therapy

    Procedure: Shock Wave Therapy with Traditional Physical Therapy

Interventions

  • ProcedureExtracorporeal Shock Wave Therapy (ESWT)

    Participants will receive 12 sessions of extracorporeal shock wave therapy (ESWT) alone, administered at a frequency of two sessions per week for a total duration of one and a half months.

  • ProcedureShock Wave Therapy with Traditional Physical Therapy

    Participants will receive 12 sessions of extracorporeal shock wave therapy combined with traditional physical therapy, administered at a frequency of two sessions per week for a total duration of one and a half months.

06

What researchers measure

Primary outcomes

  1. Shoulder pain (measured via numeric anlage scale)

    Time frame: Pre-post evaluation conducted across a treatment period of one and a half months (totaling 12 sessions at a frequency of two sessions per week).

  2. Shoulder range of motion (measured via electronic goniometer)

    Time frame: Pre-post evaluation conducted across a treatment period of one and a half months (totaling 12 sessions at a frequency of two sessions per week).

Secondary outcomes

  1. Shoulder function (assessed by shoulder joint functional index)

    Time frame: Pre-post evaluation conducted across a treatment period of one and a half months (totaling 12 sessions at a frequency of two sessions per week).

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • • V. Chauhan et al.:Effect of deep transverse friction massage and capsular stretching in idiopathic adhesive capsulitis Indian J. Physiother Occup. Ther. (2011)
  • • K. Bansal et al.: A comparative study between the efficacy of therapeutic ultrasound and soft tissue massage (deep friction massage) in supraspinatus tendinitis Indian J. Physiother Occup. Ther. (2011)
  • Simplicio CL, Purita J, Murrell W, Santos GS, Dos Santos RG, Lana JFSD. Extracorporeal shock wave therapy mechanisms in musculoskeletal regenerative medicine. J Clin Orthop Trauma. 2020 May;11(Suppl 3):S309-S318. doi: 10.1016/j.jcot.2020.02.004. Epub 2020 Feb 12. PubMed 32523286 ↗
  • https://www.sciencedirect.com/science/article/pii/S0749806315005800
  • https://www.sciencedirect.com/science/article/pii/S1017995X16302401
  • https://www.sciencedirect.com/science/article/pii/S2468781217301480
  • https://www.sciencedirect.com/science/article/pii/S2468781219300116

Individual participant data

Plan to share: Undecided — Data will be shared upon reasonable request from the principal investigator.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Jan 2027, 2 months later.

Of 173 non-industry interventional studies with no phase under Tendinopathy, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 37. This study's planned 2 months is below that.

Counting every sponsor, half of 182 studies reached it within 20 months; a quarter within 7 and three quarters within 37.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 10, 2026
First posted
Nov 16, 2026
StartEst.
Nov 10, 2026
Primary completionEst.
Jan 10, 2027
CompletionEst.
Jan 11, 2027
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07939256
Responsible party
yasmein mohammed mahmoud (Dr, Kafrelsheikh University) — Principal investigator
First posted
Nov 16, 2026
Start date
Nov 10, 2026 (estimated)
Primary completion
Jan 10, 2027 (estimated)
Completion
Jan 11, 2027 (estimated)
Last update
Nov 16, 2026

Study contacts

Reda Fathi Elbosaty, bachelor student
Contact
redafathi015@gmail.com
+201555401579
Yasmein Mohammed Mahmoud, PhD
principal investigator · faculty of physical therapy, kafr elshiekh university
Reda Fathi Elbosaty, bachelor student
principal investigator · faculty of physical therapy, kafr elshiekh university
Mohammed Abdelaziz Emam, master degree, Ass.lecturer
principal investigator · faculty of physical therapy, kafr elshiekh university

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion